Refco, a leading independent broker of derivatives, foreign currency and fixed income products, priced 26.5 million shares at $22 on Wednesday night, above its proposed $19 to $21 price range. The company originally planned to offer 25 million shares. CS First Boston, Goldman Sachs and Banc of America were the lead underwriters on the deal. The stock is expected to begin trading Thursday on the NYSE under the ticker RFX.
